title: Does mass spectrometric breath analysis detect Pseudomonas aeruginosa in cystic fibrosis?
authors: National Heart and Lung Institute, Imperial College, London, UK Dept of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, UK r.pabary11@imperial.ac.uk.
authors: Rishi
authors: R
authors: Pabary
authors: Dept of Surgery and Cancer, St Mary's Hospital, London, UK.
authors: Juzheng
authors: J
authors: Huang
authors: Dept of Surgery and Cancer, St Mary's Hospital, London, UK.
authors: Sacheen
authors: S
authors: Kumar
authors: National Heart and Lung Institute, Imperial College, London, UK.
authors: Eric W F W
authors: EW
authors: Alton
authors: National Heart and Lung Institute, Imperial College, London, UK Dept of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, UK.
authors: Andrew
authors: A
authors: Bush
authors: Dept of Surgery and Cancer, St Mary's Hospital, London, UK.
authors: George B
authors: GB
authors: Hanna
authors: National Heart and Lung Institute, Imperial College, London, UK Dept of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, UK.
authors: Jane C
authors: JC
authors: Davies
mesh_terms: D015415:Biomarkers / Q000032:analysis; D001944:Breath Tests / Q000379:methods*; D003550:Cystic Fibrosis / Q000150:complications* / Q000382:microbiology; D006801:Humans; D016015:Logistic Models; D013058:Mass Spectrometry; D011552:Pseudomonas Infections / Q000175:diagnosis*; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification*; D055549:Volatile Organic Compounds / Q000032:analysis*
chemical_list: D015415:Biomarkers; D055549:Volatile Organic Compounds